UBS MSCI Switzerland 20/35 UCITS ETF CHF Ukdis

What this fund is

UBS MSCI Switzerland 20/35 UCITS ETF CHF Ukdis is an exchange-traded fund (ETF) from UBS, traded under the ticker 0HCN (ISIN LU1107560036). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, focused on the European market. It passively tracks the MSCI Switzerland 20/35 index — mirroring that market instead of paying a manager to pick winners, which keeps costs low, and its largest holdings include ROCHE HLDG PC PRP, NOVARTIS AG-REG and NESTLE SA-REG. Geographically it leans ~75.4% Switzerland.

Its heaviest sectors are ~30.7% Health Care and ~15.5% Financials. Funds like this are commonly chosen by investors who want a regular cash income stream rather than reinvesting everything for growth. Its ongoing charge (TER) is 0.2% a year — about €20 a year on a €10,000 holding, taken automatically from the fund. It is a distributing share class — dividends are paid to you as cash rather than reinvested, and over the last year it paid out roughly 0.01% (its trailing yield). It holds the underlying investments directly (physical replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in CHF.

Its price has swung about 12.2% over the past year — a gauge of how much the value moves, not a judgement of quality. It launched in 2014. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from UBS.)